OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Bruno Vellas

1 Projects | 1 Researchers | $300,000 Invested

2016

Toulouse Centre of Excellence in Neurodegeneration, University Hospital Toulouse

Bruno Vellas, MD

Prevention of cognitive decline in older adults with low DHA/EPA index in red blood cells (Acronym : MAPT 2)

  • Funding Amount: $300,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Other
  • Status: Closed